p38 MAPK in MDS

Myelodysplastic syndromes (MDS) are a group of heterogeneous hematopoietic malignancies occurring mainly in the elderly and characterized by the defective production of mature blood cells. MDS subtypes can be classified as “low-risk” and “high-risk” syndromes on the basis of their risk of progressio...

Descripción completa

Detalles Bibliográficos
Autores: Gañán-Gómez, I. (Irene)|||/items/92d1787d-8a7f-414a-af8a-a0cc2094a8af, Bohannan, Z.S. (Zachary S.)|||/items/b0689a88-8053-47de-bc50-84386af19b10, Garcia-Manero, G. (Guillermo)|||/items/e2797ef5-c469-437c-afb3-e178412217ce
Tipo de recurso: artículo
Fecha de publicación:2015
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/121365
Acceso en línea:https://hdl.handle.net/10171/121365
Access Level:acceso abierto
Palabra clave:Myelodysplastic syndromes (MDS)
ARRY-614
Descripción
Sumario:Myelodysplastic syndromes (MDS) are a group of heterogeneous hematopoietic malignancies occurring mainly in the elderly and characterized by the defective production of mature blood cells. MDS subtypes can be classified as “low-risk” and “high-risk” syndromes on the basis of their risk of progression to acute leukemia.